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Various domains present the challenges of responding to stimuli in a specific manner, with the desired 
sensitivity or functionality, and only when required. Stimuli-responsive systems that are appropriately 
designed can effectively meet these challenges. Here, we introduce nanoreactors that encapsulate 
photosensitizer-protein conjugates in polymer vesicles as a source of “on demand” reactive oxygen 10 
species. Vesicles made of poly-(2-methyloxazoline)-poly (dimethylsiloxane)-poly (2-methyloxazoline) 
successfully encapsulated the photosensitizer Rose Bengal-bovine serum albumin conjugate (RB-BSA) 
during a self-assembly process, as demonstrated by UV-Vis spectroscopy. A combination of light 
scattering and transmission electron microscopy indicated that the nanoreactors are stable over time. They 
serve a dual role: protecting the photosensitizer in the inner cavity, and producing in situ reactive oxygen 15 
species (ROS) upon irradiation with appropriate electromagnetic radiation. Illumination with appropriate 
wavelength light allows us to switch on/off and to control the production of ROS. Because of the oxygen-
permeable nature of the polymer membrane of vesicles, ROS escape into the environment around 
vesicles, as established by electron paramagnetic resonance. The light-sensitive nanoreactor is taken up 
by HeLa cells in Trojan horse fashion: it is nontoxic and, when irradiated with the appropriate laser light, 20 
produces ROS that induce cell death in a precise area corresponding to the irradiation zone. These 
nanoreactors can be used in theranostic approaches because they can be detected via the fluorescent 
photosensitizer signal and simultaneously produce ROS efficiently “on demand”. 
Introduction 
Design of stimuli-responsive systems, where a rapid and specific 25 
response to changes in environmental conditions serves to sense- 
/deliver molecules or to induce processes, is in focus today in 
various domains such as medicine, material science, food science. 
Stimuli-responsive systems containing polymers are based either 
on a responsive polymer or on a combination of a responsive 30 
compound and a polymer supramolecular assembly serving as the 
carrier/template for the compound. A smart response to external 
or internal stimuli facilitates controlled release of a payload at a 
desired region, precise activity modulated by stimuli, or rapid 
imaging of a pathological event.1 A large variety of polymers 35 
have been synthesized to response to physical, chemical or 
biological stimuli by undergoing dramatic physical or chemical 
changes in reply to stimulus presence.2 One important feature of 
this type of material is reversibility, i.e. the ability of the polymer 
to return to its initial state upon application of a stimulus for a 40 
defined period of time.  
In particular, polymer supramolecular assemblies such as 
micelles, capsules, and vesicles reply to a stimulus by changing 
their architecture or properties.3 Polymers have proven 
themselves clever options in developing stimuli-responsive 45 
systems because their chemical nature permits modulating their 
properties by including responsiveness via sensitive chemical 
moieties. Typically, the ‘response’ of a polymer in solution is 
based on changes to its individual chain size, secondary structure, 
solubility, or degree of intermolecular association.4 Systems that 50 
are based on a dramatic alteration of the polymer structure 
inducing a disintegration of their architecture during their contact 
with the stimulus, and subsequent release of payload, represent 
the majority of the stimuli-responsive materials reported so far.5 
Meanwhile, there is a limited number of polymer supramolecular 55 
assemblies that contain responsive payloads and that preserve 
assembly architecture while the active compound acts inside 
when in contact with the stimulus. Polymer vesicles containing a 
pH-controlled enzyme have been described as a first example of a 
biohybrid nanoreactor that responds to pH changes present 60 
outside the polymer assemblies.6 The pH-responsive system is 
described as a model that can be further exploited for medical 
applications.  
Nanoreactors consist of compartments, for example polymer 
vesicles, that encapsulate an active molecule/combination of 65 
molecules protected from degradation inside the compartment, 
and simultaneously acting in situ.7 Various types of nanoreactors 
have been introduced by the encapsulation of enzymes or 
mimics.8-10 However, to act in a stimuli-responsive manner, with 
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a rapid, easy switching on/off, nanoreactors have to be designed 
with stimuli-responsive active compounds and should avoid 
limitations that could result from the consumption of reactants, or 
activity in other regions/times than those desired.  
 5 
Here, we introduce stimulus-responsive nanoreactors based on 
the encapsulation of a highly active photosensitizer-protein 
conjugate in polymer nanovesicles. Stimulus-responsiveness is 
obtained by the property of the photosensitizer-protein conjugate, 
generating in situ ROS in the cavities of the nanoreactors only 10 
when irradiated with the corresponding wavelength of light 
(Figure 1). ROS production can thus be switched on/off and 
controlled by appropriate light-irradiation. We selected poly(2-
methyloxazoline)-block-poly(dimethylsiloxane)-block-poly(2-
methyloxazoline) (PMOXA-PDMS-PMOXA) triblock 15 
copolymer, which has already been reported to generate stable, 
self-assembled vesicular structures in aqueous media8 with 
oxygen permeable membranes.11 Due to the specific chemistry of 
the PMOXA-PDMS-PMOXA, which renders the membrane 
permeable to ROS but impermeable to small molecules such as 20 
water or urea,12 nanoreactors will preserve the photosensitizer-
protein conjugate inside, while allowing in situ generated ROS to 
escape the vesicle. In addition, both polymer vesicles and 
nanoreactors based on PMOXA-PDMS-PMOXA copolymers 
have already been shown to be taken-up and to preserve their 25 
morphology inside cells.13 Improvement of up-take has been 
reported by functionalisation with specific molecules (antibodies 
or ligands), which leads to the successful targeting of desired 
cells.14, 15 
 30 
Fig. 1 Schematic representation of polymeric nanoreactors that serve as a 
source of reactive oxygen species “on demand”. When irradiated with an 
appropriate wavelength, and in the presence of oxygen, the 
photosensitizer-protein conjugate generates ROS, which pass through the 
polymer membrane in the environment of vesicles. 35 
We chose a photoactive dye, Rose Bengal (RB), as the active 
molecule in the nanoreactor,16 because this di-anionic 
photosensitizer is known to convert oxygen to reactive oxygen 
species (ROS), such as O2.- and 1O2. with a high quantum yield.
17, 
18 Photosensitizers have already been used to produce ROS for 40 
the treatment of age-related macular degeneration, burns, ulcers, 
cancer and dermal applications.19, 20 To increase RB 
hydrophilicity, and therefore to improve the encapsulation 
efficiency, RB was conjugated to the stable and robust protein, 
bovine serum albumin (BSA).21 We investigated, by a 45 
combination of spectroscopy and electron spin resonance (ESR), 
in situ production of ROS, while light scattering (LS) and 
transmission electron microscopy (TEM) allowed us to asses the 
morphology and stability of nanoreactors before and after light-
irradiation. 50 
Our system will act like a Trojan horse to induce cell death “on 
demand,” because it is designed to be taken-up by cells with no 
consequent toxicity, while inducing cell death upon production of 
ROS under laser light irradiation at a specific wavelength. Our 
nanoreactors support theranostic approaches because they play a 55 
dual role: the role needed in diagnostic application – easy 
detection– and that required in therapeutics – inducing cell death 
under controlled circumstances22. As an example of possible 
medical application, we tested our light-responsive nanoreactors 
in cell lines for photodynamic therapy (PDT), which is expected 60 
to gain full potential if drawbacks such as the inherent systemic 
toxicity of photosensitizers23, 24 can be eliminated by nanoreactor 
use.  
Experimental 
Chemicals were purchased from Sigma-Aldrich at the highest 65 
purity and were used without further treatment. 
Polymer synthesis 
We used the copolymer PMOXA10-PDMS87-PMOXA10, as 
synthesized by Egli et. al. (Figure S1).25 
Rose Bengal – BSA conjugation: 20 mg (300 µM) bovine serum 70 
albumin (BSA) were dissolved in 1 ml PBS solution containing 
100 µM Rose Bengal (RB). After 1 h at room temperature the 
solution was applied to a HiTrapDesalting column containing 
SephadexTM Superfine (GE Healthcare, UK). 
RB-BSA encapsulation in polymer vesicles 75 
The film rehydration method was used to prepare vesicles with 
encapsulated RB-BSA conjugates.26 5 mg of PMOXA10-PDMS87-
PMOXA10 were dissolved in EtOH and transferred into a 10 ml 
round-bottom flask. EtOH was evaporated at a reduced pressure 
of 150 mbar in a rotary vacuum evaporator (Büchi Rotavaport R-80 
124 with vacuum controller B-721, Büchi Switerzland) at 40 °C, 
while rotating at 100 rpm to obtain a polymer film on the inner 
glass surface of the flask. 1 ml PBS containing RB-BSA 
conjugates (50 µM RB; 150 µM BSA) was added to the film 
under continuous stirring overnight at room temperature under 85 
atmospheric pressure. The obtained vesicle solution was extruded 
with a LiposoFast-Basic extruder (Avestin, Canada) through a 0.2 
µM Nucleopore Track-Etch membrane from Whatman (11 times). 
The extruded vesicle solution was applied to a size exclusion 
chromatography (SEC) column filled with Sepharose 2B 90 
connected to an ÄKTA prime (GE Healthcare, UK). Control 
vesicles were prepared by applying a solution to the Sepharose 
2B column, containing a premix of 500 µl 5 mg/ml empty 
polymer vesicles and 500 µl RB-BSA conjugate solution. The 
control vesicles were tested after SEC for the presence of RB and 95 
BSA by UV-Vis spectroscopy at 560 nm and SDS-PAGE, 
respectively.  
Rose Bengal – BSA conjugate detection 
A calibration curve based on the absorbance maxima at 560 nm 
of a RB-BSA conjugate was established, with a dilution series 100 
ranging from 1 µM to 100 µM RB-BSA conjugate 
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concentrations. The SEC-fraction-containing vesicles with 
encapsulated RB-BSA conjugates were analysed with UV-Vis 
spectroscopy (SpectraMax M5e,Molecular Devices, USA) at 560 
nm. The absorbance curves were background corrected and the 
obtained intensities were compared with the standards resulting 5 
from the dilution series. The volumes of the fraction containing 
RB-BSA nanoreactors were determined in order to calculate the 
volume-corrected encapsulation efficiency.  
Light scattering 
Light scattering experiments were performed using an ALV 10 
goniometer (ALV GmbH, Germany) equipped with an ALV He-
Ne laser (JDS Uniphase, wavelength λ = 632.8 nm). The vesicle 
solution (1 mg/ml, 0.5 mg/ml 0.4 mg/ml and 0.33 mg/ml) was 
measured in a 10 mm cylindrical quartz cell at angles ranging 
from 40° to 150° at 273 K. ALV / Static & Dynamic FIT and 15 
PLOT program version 4.31 10/10 was used in the process. Static 
light scattering data were processed according to the Guinier-
model. 
Transmission electron microscopy 
10 µl empty polymer vesicle solution and an RB-BSA conjugate-20 
loaded polymer vesicle solution were negatively stained with 2% 
uranyl acetate solution and deposited on a carbon-coated copper 
grid. The samples were examined with a transmission electron 
microscope (Philips Morgani 268 D) operated at 80 kV. 
Electron spin resonance 25 
TMP-OH powder was weighed and a solution with the same 
amount of RB was added to the powder to obtain a concentration 
of 200 µM. In the case where RB, RB-BSA, and the vesicle 
solution did not have the same absorbance at 550 nm and 560 nm, 
the sample was diluted with PBS until they all had the same RB 30 
concentration. The ESR experiments were carried out at room 
temperature using an ESP300E spectrometer (Bruker BioSpin, 
Germany) operating at the X-band frequency and equipped with a 
standard rectangular mode TE102 cavity. Samples were transferred 
to 0.7 mm ID and 0.87 mm OD glass capillary tubes (VitroCom, 35 
NJ, USA), with sample height ~ 50 mm (~20 microliter), and 
sealed on both sides with Cha.seal (tube sealing compound, 
Chase Scientific Glass, Rockwood, TN, USA). An assembly of 
seven tightly packed capillaries was bundled together and 
inserted into a wide-bore quartz capillary (standard ESR quartz 40 
tube with 2.9 mm ID and 4 mm OD, Model 707-SQ-250M, from 
WilmadGlass Inc., Vineland, NJ, USA) This setup resulted in ca. 
140 microliter sample volume in the active zone of the TE102 
cavity. The samples were illuminated with visible light and 
measured with the typical instrument setting: microwave 45 
frequency 9.77 GHz, microwave power 10.1 mW, sweep width 
100 G, modulation frequency 100 kHz, modulation amplitude 0.5 
G, receiver gain 2 x 104, time constant 81.92 ms, conversion time 
40.96 ms and total scan time 41.9 s. 
Cell toxicity assay 50 
2 x 104 HeLa cells per well were cultured in Dulbecco’s Modified 
Eagle’s Medium (DEME) containing 10% fetal calf serum (FCS) 
for 24 h in a 96-well plate and then incubated with different 
concentrations of polymersomes [50, 100, 200, 300 µg/ml]. The 
cells were grown for another 24 h in the presence of the 55 
polymersomes at 37 °C and 5% CO2 atmosphere. Cell viability 
was tested using the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)- 
2H-tetrazolium) assay (Promega, USA). After 1 h of incubation 
with MTS the absorbance of each well was measured at 490 nm 60 
with a microplate reader (SpectraMax M5, Molecular Devices, 
USA) 
Uptake studies and photosensitizing activity tests 
HeLa cells were cultured at a density of 5 x 104 cells per well in 
an 8-well Lab-TekTM (Nalge Nunc International, USA) for 24 h 65 
in DEME growth medium to allow attachment to the surface. 
After attachment, the medium was removed and polymer vesicles 
containing RB-BSA conjugates were added and incubated for an 
additional 20 h in DEME growth medium without FCS. The pre-
treated HeLa cells containing the RB-BSA nanoreactors were 70 
further incubated at 37 °C with freshly prepared Deep Red 
(CellmaskTM) plasma membrane stain (5 µg/ml) and Hoechst 
3342 (5 µg/ml) dsDNA stain for 10 min. The cells were washed 
three times with PBS buffer and visualized with a confocal laser 
scanning microscope (Carl Zeiss LSM510, Germany) equipped 75 
with a 63x water emulsion lens (Olympus, Japan). The 
measurements were performed in multitrack mode, and the 
intensity of each fluorescent dye was adjusted individually: 
Hoechst 3342 was excited at 405 nm in channel 1, Deep Red at 
633 nm in channel 2 and RB-BSA at 543 nm in channel 3. The 80 
images were recorded using Carl Zeiss LSM software (version 
4.2 SP1). 
During irradiation experiments, cells were visualized first using 
405 nm and 633 nm lasers. The 543 laser was used as an 
excitation source for the cells in a defined area at 23.7 J/cm2. 85 
Subsequently, the area was visualized using 405 nm and 633 nm 
laser light. This was repeated several times followed by a 
visualization of a larger area that included the defined area. 
Results and discussion 
We generated the stimulus-responsive nanoreactors in a 90 
straightforward manner: the self-assembly process of amphiphilic 
copolymers in the presence of photosensitizers induced the 
formation of supramolecular assemblies containing the 
photosensitizers inside. The inherent conditions that support the 
functionality of a nanoreactor are high encapsulation efficiency 95 
for the active compound (in our case the photosensitizer), and the 
ability of that photosensitizer to act in situ, inside the polymer 
assembly. In this respect we first improved the solubility of the 
photosensitizer that we chose as the active compound. 
Nanoreactors: generation and characterisation 100 
In order to improve solubility and therefore increase the 
encapsulation efficiency, we conjugated the photosensitizer RB 
with bovine serum albumin (BSA), which is known to be stable 
and favors a hydrophobic interaction with RB.27, 28 In addition, 
the conjugation of RB to BSA avoids interaction with the 105 
polymer membrane due to the hydrophilic character of BSA. The 
successful conjugation was proved by the shift in the maximum 
absorbance from λ = 547 nm to λ = 559 nm (Figure S2).[35] To 
encapsulate RB-BSA photosensitizers inside polymer assemblies 
of PMOXA10-PDMS87-PMOXA10 we used the film rehydration 110 
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method.26 
The nanoreactors were extruded to control their size and reduce 
polydispersity and further purified by size exclusion 
chromatography (SEC). To determine whether RB-BSA 
conjugates bind unspecifically to the nanoreactors, all fractions 5 
obtained after purification of a mixture of empty polymer 
assemblies and RB-BSA were collected and loaded onto SDS 
acrylamide gel; no RB-BSA conjugate was present in the vesicle 
fraction (Figure S3). This shows that RB-BSA does not interact 
with the polymer membrane, as expected, due to the hydrophilic 10 
character of BSA. In addition fluorescence measurements 
indicate that there is no change in the emissionwavelength of RB-
BSA both in the presence of polymer vesicles, and when it is 
encapsulated in nanoreactors (Figure S4). Therefore, during the 
self-assembly process of vesicles formation, RB-BSA is 15 
encapsulated in the aqueous cavity of vesicles. 
Table 1 Static and dynamic light scattering data for polymer vesicles and RB-BSA nanoreactors. The radius of gyration (Rg) and the hydrodynamic radius 
(Rh) were calculated with SLV/static & Dynamic Fit and PLOT software (Figure S5). 
 Rg Rh Mw, g mol
-1
 A2 mol dm
3
/g
2
 Rg/Rh 
Empty vesicles 107 ± 3 nm 112 ± 3 nm 1.83 x 10
9
 3.388 x 10
-10
 0.96 
RB-BSA 
nanoreactors 
105 ± 2 nm 110 ± 2 nm 1.33 x 10
9
 2.662 x 10
-10
 0.95 
After one month at room temperature 
Empty vesicles 106 ± 2 nm 115 ± 3 nm 1.18 x 10
9
 3.388 x 10
-10
 0.96 
RB-BSA 
nanoreactors 
103 ± 4 nm 109 ± 5 nm 1.34 x 10
9
 2.712 x 10
-10
 0.95 
 
 
Nanoreactors were characterized using light scattering and 20 
transmission electron microscopy, and compared with polymer 
assemblies without photosensitizers (Table 1). In both cases the 
ratios of Rg to Rh were calculated to values close to 1, showing 
that nanoreactors and polymer assemblies are made of vesicles.29 
Similar sizes in both cases indicate that the encapsulation of 25 
photosensitizers affect neither the morphology of polymer 
assemblies, nor their size. Our analysis yields A2 values ≈ 0, 
within experimental error (i.e., no long-range interactions 
between the vesicles in the concentration range investigated). 
Transmission electron microscopy (TEM) micrographs of empty 30 
vesicles (Figure 2A) and RB-BSA nanoreactors (Figure 2B) 
reveal collapsed vesicular structures in good agreement with the 
light scattering data. The stability of nanoreactors over time is an 
important parameter for their application; to determine stability, 
nanoreactors were stored for one month at room temperature 35 
while protected from light. The obtained values of Rg and Rh did 
not change over this period (Table 1), an observation supported 
by TEM micrographs as well. Stability studies with PMOXA-
PDMS-PMOXA vesicles with different block lengths in blood 
plasma showed stability over several hours.30 Illumination of 40 
vesicles/nanoreactors with light (405 nm, 543 nm, and 633 nm) 
did not change the morphology or size of vesicles. The high 
stability of polymer vesicles supports their prospective 
applications in medicine and technology.  
The concentration of RB-BSA conjugates inside the cavity of 45 
nanoreactors was estimated by comparing them spectroscopically 
with a dilution series of known RB-BSA concentrations. The 
volume-corrected encapsulation efficiency was calculated as 13% 
(4 µM concentration of RB-BSA inside nanoreactors). The 
quantity of RB-BSA conjugates inside the nanoreactors was at 50 
the same order of magnitude as that previously used for other 
PDT studies (10 – 40 µM RB).31  
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Fig. 2 TEM micrographs of freshly prepared: polymer vesicles A), and RB-BSA nanoreactors B) (black scale bars: 200 nm). 
Nanoreactor activity 
While the conjugation of RB to peptides was shown not to inhibit 
the photoactive property,32 the effect of conjugation with the BSA 5 
protein has not been reported. Therefore, we first investigated the 
photodynamic activities of RB and RB-BSA conjugates using 
ESR. The formation of 1O2 upon illumination of RB/RB-BSA 
conjugates with a visible light source was followed by means of 
the appearance of a paramagnetic species as the product of the 10 
reaction of 1O2 and a scavenging molecule. We selected 2,2,6,6-
tetramethyk-4-piperidinol, TMP-OH, as the scavenging molecule 
because it is diamagnetic and therefore ESR silent (Figure 3). 
Upon reaction with 1O2, it produces TEMPOL, a paramagnetic 
species, with a well resolved ESR spectrum, the integral of which 15 
is proportional to the amount of 1O2.
33 In addition, the formation 
of TEMPONE, a product of the partial decay of TEMPOL due to 
attack by O2.-, can be observed by ESR as well. 
Fig. 3 TMP-OH, as an ESR silent molecule, reacts in the presence of 1∆g 
to form TEMPOL, which is detectable via ESR measurement. 20 
 
The RB/RB-BSA conjugate solutions were first measured with 
ESR without illumination: no ESR signal was obtained. Upon 
homogeneous illumination with visible light for increasing 
periods of time (up to 20 minutes), ESR spectra indicated the 25 
formation of paramagnetic species. We observed not only the 
formation of TEMPOL (g = 2.0055, aN = 17.13 G) but also the 
formation of TEMPONE (g = 2.0054, aN = 16.13 G) (Figure 4A). 
The integrals of the ESR spectra were used as a quantitative value 
for TEMPOL and TEMPONE concentration. As expected, RB 30 
was able to produce TEMPOL and TEMPONE at the highest 
efficiency (Figure 4B-a). RB-BSA conjugates preserved 70% of 
photodynamic activity after 20 min illumination (Figure 4B-b). 
Due to the high photodynamic efficiency of RB, the ROS 
generated by RB-BSA conjugates is high enough for application 35 
in medical domain, for example to PDT. In addition, the 
photodynamic activity of the conjugate can be further improved 
by using an appropriate laser light source that is known to have a 
higher efficiency in activating RB.27 
ESR was further used to study the generation of ROS inside 40 
nanoreactors, and their escape through the polymer membrane. It 
was already proven that the PMOXA-PDMS-PMOXA membrane 
is permeable to ROS,11 while it is not permeable to small 
molecules, such as water.12, 13, 34 As the nanoreactor membrane is 
impermeable to TMP-OH, its conversion to the stable TEMPOL 45 
and TEMPONE paramagnetic species takes place only outside 
the vesicles. Therefore, the formation of TEMPOL and 
TEMPONE in the environment of vesicles represents a direct 
indicator of the production of ROS inside the nanoreactor, and 
their escape through the polymer membrane. For comparable 50 
results of ESR measurements, solutions containing RB, RB-BSA 
conjugates and RB-BSA nanoreators were diluted to the same RB 
concentration, which was determined with UV-VIS spectroscopy 
by making a comparison at absorbance intensity of λ = 550 nm 
and λ = 560 nm. ESR spectra of RB, RB-BSA and RB-BSA 55 
nanoreactors were measured with and without increasing 
illumination times under similar conditions as mentioned above. 
Spectra integrals indicate that, after 20 min illumination, RB-
BSA conjugates and RB-BSA nanoreactors preserved around 
70% of the initial photodynamic activity of RB (Figure 4B-b and 60 
c). As there is no significant difference in the photodynamic 
efficiency when RB-BSA is encapsulated in the polymer vesicles, 
this clearly indicates that the polymer membrane does not 
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influence the efficacy of the nanoreactors in terms of the ROS 
amount provided outside the vesicles. As expected, empty 
polymer vesicles were not been involved in the production of 
ROS upon irradiation (they were ESR silent, Figure 4B-d). 
 5 
Fig. 4 A) ESR spectra of: RB (a), RB-BSA conjugates (b), nanoreactors (c) and empty vesicles (d). B) Integrals of the ESR spectra as a function of 
illumination time for: RB (a, ■), RB-BSA (b, ●), nanoreactors (c, ♦), and empty vesicles (d, ►). 
ROS production “on demand” by nanoreactors inside cells 
The internalization, stability, and in situ activity of nanoreactors 
have been tested on HeLa cancer cells. For further medical 10 
applications it is important that RB-BSA nanoreactors be 
delivered to cells without being denatured and with low dark 
toxicity (damage to cells in dark conditions). There was no 
noticeable difference in cell viability between cells incubated 
with polymer vesicles/nanoreactors, and untreated HeLa cells, as 15 
measured using an MTS assay. Cell viability was over 90% up to 
a polymer vesicle concentration of 300 µg/ml (Figure 5). In 
addition, there was no difference in dark toxicity between empty 
vesicles and nanoreactors (polymer vesicle concentration between 
50 and 300 µg/ml), in agreement with previous reports on low 20 
cytotoxicity of PMOXA-PDMS-PMOXA polymer vesicles with 
different block lengths, in other cell lines.35, 36 
Fig. 5 HeLa cell viability after 24 h incubation in dark conditions with: 
nanoreactors (black), and empty vesicles (white). Untreated cells are 
considered 100% viable. 25 
We used laser scanning microscopy (LSM) to examine both the 
uptake and the photosensitizing activity of RB-BSA-containing 
nanoreactors in HeLa cells. In normal culture conditions, 
untreated HeLa cells form a semi-confluent layer composed of 
individual, adhered, flat cells, both in dark and when illuminated 30 
by light (Figure 5A). To improve the uptake of nanoreactors, 
HeLa cells were incubated with polymer vesicles/nanoreactors in 
a medium without bovine calf serum, to favour uptake. In the 
intracellular regions of damaged cells (Figure 6B) we observed a 
fluorescent signal specific for the RB-BSA-conjugate, which has 35 
the excitation wavelength at 543 nm (Figure S4). As PMOXA-
PDMS-PMOXA vesicles are stable inside cells for more than 48 
hours,13, 35 and RB-BSA cannot escape from their cavities; the 
fluorescent signal in LSM micrographs clearly indicates the 
uptake of nanoreactors (Figure 6B and 6C).  40 
To test the stimulus-responsive activity of RB-BSA nanoreactors, 
HeLa cells incubated with nanoreactors were irradiated with 
various laser wavelengths (405, 543, and 633 nm). Upon 
irradiation with 543 nm laser light the nanoreactors become 
fluorescent (red dots), and therefore their up-take can be 45 
observed. After irradiation with 543 nm laser wavelength the cell 
membranes of HeLa cells that have nanoreactors taken-up start to 
shrink and form blebs after a few tens of seconds of irradiation, 
while normal cells untreated with nanoreactors preserve their 
shape and integrity. Formation of blebs has already been reported 50 
for HeLa cells when RB was irradiated in situ by a laser with a 
wavelength of 530 nm, but only 24 h after irradiation.37 Here, we 
observed significant bleb formation within a few minutes after 
the irradiation of nanoreactor-containing cells, at a laser intensity 
of 23.7 J/cm2. The irradiation conditions that we chose are similar 55 
to normal PDT treatment conditions (dose 30 – 135 J/cm2 and 
time 5 – 30 min), in order to investigate possible application in 
the medical domain.38-40 Controlled production of ROS was 
obtained by varying the illumination time and the laser intensity. 
The significant decrease in the time necessary to induce cell death 60 
when nanoreactors are active allows a decrease in the overall 
dose of irradiation necessary to produce a required cytotoxic 
effect. The longer the time of irradiation, the larger the blebs and 
the greater the cell deaths induced. The formation of blebs was 
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only observed for cells exposed to a laser wavelength of 543 nm 
(Figure 6E), but not to other wavelengths of 405 nm and 633 nm 
(Figure 5D). In cells incubated for 24 hours with RB-BSA 
nanoreactors and irradiated with an inappropriate wavelength, no 
visible phototoxic effect was observed, with cells preserving the 5 
integrity of their plasma membrane and remaining intact (Figure 
6D).[44] 
Moreover, cells incubated for 24 hours with nanoreactors that 
were close to the area irradiated with 543 nm laser (white square 
area in Figure 6F), but not directly exposed to irradiation, 10 
preserved their integrity (environment of white square area, 
Figure 6F). Together with the significant changes in cell integrity 
when irradiated with the appropriate laser wavelength, this 
indicates that the nanoreactors generate ROS only “on demand” 
and that the affected area corresponds to the irradiation surface. 15 
In this respect, the stimulus-responsive RB-BSA nanoreactors 
serve to produce ROS in the desired region, but without affecting 
other close regions. Irradiation for longer periods of time (up to 
10 minutes) induced severe changes in cell morphology up to the 
death of cells. This clearly indicates the mediated ROS 20 
phototoxicity of RB-BSA nanoreactors when switched on by 
irradiation of the appropriate laser wavelength. 
 
Fig. 6 Confocal laser scanning micrographs of HeLa cells, where the membrane (green, stained with Cell Mask Deep Red 5 µg/ml for 5 min) and the 
DNA (violet, stained with Hoechst 33342 10 µg/ml for 10 min) are fluorescently labeled: A) untreated cells growth, B) cells treated with RB-BSA 25 
nanoreactors, and irradiated with laser light at 405 nm, 543 nm, and 633 nm, for 0.5 min, C) zoom-in of HeLa cells treated with RB-BSA nanoreactors, D) 
cells treated with RB-BSA nanoreactors, and irradiated with laser light at 405 nm and 633 nm laser, for 5 min, E) HeLa cells from C) additionally 
irradiated with laser light at 543 nm, and measured without 543 nm channel F) surrounding area of C) and E) where no laser light was applied outside the 
white square (length of scale bar: A: 30 µm, B and F: 50 µm, C, D and E: 20 µm). RB-BSA nanoreactors are fluorescent (red dots) upon irradiation with 
laser light at 543 nm 30 
 
Conclusions 
We have designed stimulus-responsive nanoreactors containing 
RB-BSA conjugates as an efficient source of ROS “on demand”. 
Nanoreactors are permeable to ROS, while they do not allow the 35 
photosensitizer to escape from their cavities. The confinement of 
RB-BSA inside the aqueous cavity of a nanovesicle fulfils 
various goals: i. protect the active compound from degradation or 
undesired interactions/reactions; ii. increase the amount of active 
compound inside cells by up-take of nanoreactors; and iii. 40 
decrease side effects that might be associated with inherent RB 
toxicity. 
Stimulus-responsiveness is generated by light-irradiation: our 
RB-BSA nanoreactors produce ROS only when irradiated with an 
appropriate wavelength. Our nanoreactors behave like a Trojan 45 
horse: they start to generate in situ ROS only during appropriate 
irradiation. The short response time until cells are affected by 
ROS generated inside the cavities of polymer vesicles indicates 
their high efficiency. This will serve to decrease the overall dose 
of irradiation that is necessary to produce a required cytotoxic 50 
effect. Nanoreactor functioning can be switched on/off by the 
presence of a stimulus, and controlled by the illumination 
conditions, which allows further optimisation in terms of 
controlled production of ROS. The nanoreactors containing RB-
BSA conjugaters support theranostic approaches because they 55 
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simultaneously allow detection associated with the fluorescent 
signal of the photosensitizer, and treatment by generation of 
ROS.  
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We have designed stimulus-responsive nanoreactors based on RB-BSA conjugates that can simultaneously 
be fluorescently detected and produce ROS “on demand” for theranostic applications.  
75x45mm (300 x 300 DPI)  
 
 
Page 9 of 9 Nanoscale
N
an
o
sc
al
e 
A
cc
ep
te
d 
M
an
u
sc
rip
t
